4.6 Article

A prognostic model predicted deterioration in health-related quality of life in older patients with multimorbidity and polypharmacy

期刊

JOURNAL OF CLINICAL EPIDEMIOLOGY
卷 130, 期 -, 页码 1-12

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jclinepi.2020.10.006

关键词

Multimorbidity; Polypharmacy; Elderly; Patient-centered care; Quality of life; Functional status; Prognostic model

资金

  1. German Innovation Funds [01VSF16018]
  2. Physician-Scientist Program of Heidelberg University, Faculty of Medicine
  3. NIHR Oxford Biomedical Research Council (BRC)
  4. NIHR Oxford MedTech and In-Vitro Diagnostics Co-operative (MIC)
  5. NIHR Applied Research Collaboration (ARC) Oxford and Thames Valley
  6. Oxford Martin School
  7. National Institute for Health Research School for Primary Care (NIHR SPCR Launching Fellowship)

向作者/读者索取更多资源

The study developed and validated a prognostic model to predict deterioration in health-related quality of life in older general practice patients with chronic conditions. The model, validated internally and by internal-external cross-validation, showed good discrimination, calibration, and generalizability. Variables related to chronic conditions, inappropriate medication, functional status, well-being, and HRQoL were identified as strong predictors of deterioration in HRQoL.
Objectives: To develop and validate a prognostic model to predict deterioration in health-related quality of life (dHRQoL) in older general practice patients with at least one chronic condition and one chronic prescription. Study Design and Setting: We used individual participant data from five cluster-randomized trials conducted in the Netherlands and Germany to predict dHRQoL, defined as a decrease in EQ-5D-3 L index score of > 5% after 6-month follow-up in logistic regression models with stratified intercepts to account for between-study heterogeneity. The model was validated internally and by using internal -external cross-validation (IECV). Results: In 3,582 patients with complete data, of whom 1,046 (29.2%) showed deterioration in HRQoL, and 12/87 variables were selected that were related to single (chronic) conditions, inappropriate medication, medication underuse, functional status, well-being, and HRQoL. Bootstrap internal validation showed a C-statistic of 0.71 (0.69 to 0.72) and a calibration slope of 0.88 (0.78 to 0.98). In the IECV loop, the model provided a pooled C-statistic of 0.68 (0.65 to 0.70) and calibration-in-the-large of 0 (-0.13 to 0.13). HRQoL/functionality had the strongest prognostic value. Conclusion: The model performed well in terms of discrimination, calibration, and generalizability and might help clinicians identify older patients at high risk of dHRQoL. Registration: PROSPERO ID: CRD42018088129. (c) 2020 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据